/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Comorbidity is the driver of adverse outcomes in patients with moderate aortic stenosis
Event: ESC Congress 2023
Topic: Aortic Valve Stenosis
Session: The challenging management of moderate aortic stenosis
Derivation and validation of risk score to predict mortality or heart failure-related hospitalisation based on clinical and echocardiographic factors in moderate or severe aortic stenosis
Event: ESC Congress 2023
Topic: Epidemiology, Prognosis, Outcome
Session: The challenging management of moderate aortic stenosis
Progression of different echocardiographic parameters of aortic stenosis have different clinical associations
Event: ESC Congress 2023
Topic: Valvular Heart Disease
Session: Valvular heart disease: echocardiography and beyond
Phenotyping patients with aortic stenosis using cluster analysis to determine mortality and suitability for transcatheter aortic valve replacement
Event: ESC Congress 2022
Topic: Aortic Valve Stenosis
Session: Challenges in transcatheter aortic valve intervention
CHA2DS2-VASc and CHADS2 scores for risk stratification of major adverse cardiovascular events in the COMPASS trial
Event: ESC Congress 2020
Topic: Scores
Session: Atrial Fibrillation, Platelet Aggregation and Outcomes
Effects of patient characteristics and comorbidities on temporal trends of low-flow, low-gradient aortic stenosis phenotypes
Event: ESC Congress 2020
Topic: Epidemiology, Prognosis, Outcome
Session: Valvular Heart Disease ePosters
Clinical outcomes from antihypertensive therapies in moderate or severe aortic stenosis: a systematic review and meta-analysis
Event: ESC Congress 2020
Topic: Pharmacotherapy
Session: Valvular Heart Disease ePosters
CHA2DS2-VASc and CHADS2 scores for risk stratification of major adverse cardiovascular events in the COMPASS trial
Event: ESC Asia with APSC & AFC 2020
Topic: Scores
Session: Abstract Programme
ESC 365 is supported by
